Lv51
1000 积分 2024-01-02 加入
Real-world efficacy and safety of TACE-HAIC combined with TKIs and PD-1 inhibitors in initially unresectable hepatocellular carcinoma
3小时前
已完结
Adjuvant stereotactic body radiotherapy after marginal resection for hepatocellular carcinoma with microvascular invasion: A randomised controlled trial
1个月前
已完结
Long term outcomes in patients with advanced intrahepatic cholangiocarcinoma treated with hepatic arterial infusion chemotherapy
1个月前
已完结
A preoperative scoring system to predict lymph node metastasis in intrahepatic cholangiocarcinoma
1个月前
已完结
Factor V Inhibitors: A Diagnostic and Therapeutic Challenge
1个月前
已完结
Acquired factor V inhibitor treated with rituximab
1个月前
已完结
Acquired inhibitor of factor V: first report in China and literature review
1个月前
已完结
Inherited and acquired factor V deficiency
1个月前
已完结
Acquired factor V inhibitors: a systematic review
1个月前
已完结
Acquired factor V inhibitor: a nation‐wide study of 38 patients
1个月前
已完结
皖公网安备34019202002308
